Moreover, our immunohistochemistry studies also revealed that sitagliptin was able to prevent the diabetes-induced increase in IL-1β and TNF-α mainly in the cells around the glomeruli, which are probably tubular cells and/or accumulation of interstitial inflammatory cells. The gene discussed is IL1B; the disease is diabetes mellitus.